Comparison of Lidocaine and Remifentanil for the Effect on Responses to the Endotracheal Tube During Emergence From General Anesthesia
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01082458|
Recruitment Status : Completed
First Posted : March 8, 2010
Last Update Posted : November 19, 2010
|Condition or disease||Intervention/treatment||Phase|
|Thyroidectomy||Drug: remifentanil / lidocaine||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||67 participants|
|Official Title:||Comparison of Lidocaine and Remifentanil for the Effect on Responses to the Endotracheal Tube During Emergence From General Anesthesia|
|Study Start Date :||February 2010|
|Actual Primary Completion Date :||July 2010|
|Actual Study Completion Date :||July 2010|
- Drug: remifentanil / lidocaine
Remifentanil TCI group : target controlled infusion of 2.0ng/ml of remifentanil on end of surgery.
Lidocaine IV group : Intravenous administration of 1.5mg/kg of lidocaine on end of surgery.
- Comparison of lidocaine and remifentanil for the effect on responses to the endotracheal tube during emergence from general anesthesiaThe incidence and the grade of cough during emergence from general anensthesia between remifentanil TCI group and lidocaine IV administration group.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01082458
|Korea, Republic of|
|Seoul, Korea, Republic of|